arrow
C

Christopher M. Overall

University of British Columbia
H指数:100
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AI proteomics: from protein identification to virtual cells

AI蛋白质组学:从蛋白质鉴定到虚拟细胞

2026-07-280
PRE
The 2025 Report on the Human Proteome from the HUPO Human Proteome Project

2025年人类蛋白质组计划(HUPO Human Proteome Project)的人类蛋白质组报告

2026-01-050
PRE
Finerenone prevents renal damage by enhancing SDF-1α/CXCR4-mediated stem cell mobilization in experimental type 1 diabetic nephropathy

Finerenone通过增强SDF-1α/CXCR4介导的干细胞动员,预防实验性1型糖尿病肾病中的肾损伤。

2025-11-040
OAAI
π-HuB: the proteomic navigator of the human body (Vol 636, pg 322, 2024)

π-HuB: 人体蛋白质组导航者 (Vol 636, pg 322, 2024)

NATURE
IF48.5
2024-12-230
PRE
The 2024 Report on the Human Proteome from the HUPO Human Proteome Project

HUPO人类蛋白质组计划人类蛋白质组的2024报告

2024-11-080
PRE
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens:: Disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis

在基于细胞的蛋白质组学筛选中鉴定由基质金属蛋白酶2 (MMP-2) 处理的候选血管生成抑制剂:: 通过MMP-2蛋白水解破坏血管内皮生长因子 (VEGF)/肝素affin调节肽 (pliotrophin) 和VEGF/结缔组织生长因子血管生成抑制复合物

2023-03-27197
OAAI
The 2022 Report on the Human Proteome from the HUPO Human Proteome Project

HUPO人类蛋白质组计划人类蛋白质组的2022报告

2022-11-0140
OA
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency
2021-12-0119
PREAI